These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16458317)

  • 1. Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice.
    Park TS; Panek RL; Rekhter MD; Mueller SB; Rosebury WS; Robertson A; Hanselman JC; Kindt E; Homan R; Karathanasis SK
    Atherosclerosis; 2006 Dec; 189(2):264-72. PubMed ID: 16458317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
    Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
    Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice.
    Park TS; Rosebury W; Kindt EK; Kowala MC; Panek RL
    Pharmacol Res; 2008 Jul; 58(1):45-51. PubMed ID: 18611440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration.
    Glaros EN; Kim WS; Wu BJ; Suarna C; Quinn CM; Rye KA; Stocker R; Jessup W; Garner B
    Biochem Pharmacol; 2007 May; 73(9):1340-6. PubMed ID: 17239824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate consumption of beer reduces liver triglycerides and aortic cholesterol deposit in LDLr-/- apoB100/100 mice.
    Degrace P; Moindrot B; Mohamed I; Gresti J; Clouet P
    Atherosclerosis; 2006 Dec; 189(2):328-35. PubMed ID: 16487531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic lipase expression in macrophages contributes to atherosclerosis in apoE-deficient and LCAT-transgenic mice.
    Nong Z; Gonzalez-Navarro H; Amar M; Freeman L; Knapper C; Neufeld EB; Paigen BJ; Hoyt RF; Fruchart-Najib J; Santamarina-Fojo S
    J Clin Invest; 2003 Aug; 112(3):367-78. PubMed ID: 12897204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of high-density lipoprotein levels by cholesteryl ester transfer protein expression in scavenger receptor class B type I (SR-BI) knockout mice does not normalize pathologies associated with SR-BI deficiency.
    Hildebrand RB; Lammers B; Meurs I; Korporaal SJ; De Haan W; Zhao Y; Kruijt JK; Praticò D; Schimmel AW; Holleboom AG; Hoekstra M; Kuivenhoven JA; Van Berkel TJ; Rensen PC; Van Eck M
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1439-45. PubMed ID: 20431066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
    Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
    Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice.
    Glaros EN; Kim WS; Quinn CM; Jessup W; Rye KA; Garner B
    J Lipid Res; 2008 Feb; 49(2):324-31. PubMed ID: 17978313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.
    Hojjati MR; Li Z; Zhou H; Tang S; Huan C; Ooi E; Lu S; Jiang XC
    J Biol Chem; 2005 Mar; 280(11):10284-9. PubMed ID: 15590644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sphingolipid synthesis inhibition on cholesterol gallstone formation in C57BL/6J mice.
    Lee BJ; Kim JS; Kim BK; Jung SJ; Joo MK; Hong SG; Kim JS; Kim JH; Yeon JE; Park JJ; Byun KS; Bak YT; Yoo HS; Oh S
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1105-10. PubMed ID: 20594226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine palmitoyltransferase (SPT) deficient mice absorb less cholesterol.
    Li Z; Park TS; Li Y; Pan X; Iqbal J; Lu D; Tang W; Yu L; Goldberg IJ; Hussain MM; Jiang XC
    Biochim Biophys Acta; 2009 Apr; 1791(4):297-306. PubMed ID: 19416652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
    Koulis C; Chen YC; Hausding C; Ahrens I; Kyaw TS; Tay C; Allen T; Jandeleit-Dahm K; Sweet MJ; Akira S; Bobik A; Peter K; Agrotis A
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):516-25. PubMed ID: 24436372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ces3/TGH deficiency improves dyslipidemia and reduces atherosclerosis in Ldlr(-/-) mice.
    Lian J; Quiroga AD; Li L; Lehner R
    Circ Res; 2012 Sep; 111(8):982-90. PubMed ID: 22872154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
    Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
    Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
    Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
    Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of plasma cholesterol esterification by sphingomyelin: effect of physiological variations of plasma sphingomyelin on lecithin-cholesterol acyltransferase activity.
    Subbaiah PV; Jiang XC; Belikova NA; Aizezi B; Huang ZH; Reardon CA
    Biochim Biophys Acta; 2012 Jun; 1821(6):908-13. PubMed ID: 22370449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
    J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.